Cargando…
Hyperprogressive disease after avelumab maintenance therapy in a patient with advanced ureter cancer: A case report
In the early stages of immunocheckpoint inhibitor administration, we should be aware of rapid cancer progression, known as hyperprogressive disease, in real-world clinical practice. We report a case of a 73-year-old man who presented with right abdominal pain and was diagnosed with advanced right ur...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679574/ https://www.ncbi.nlm.nih.gov/pubmed/36425905 http://dx.doi.org/10.1016/j.eucr.2022.102278 |